← Leaderboards
Lin Z Li
University Of Pennsylvania
$7,574,898
Attributed
$7,597,148
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,597,148 · 8
By mechanism
R01$7,064,446 · 3
P41$488,202 · 2
R13$44,500 · 3
Top collaborators
- Arjun G. Yodh3 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Arjun G. Yodh$14,575,682
- Corinde E Wiers$1,714,921
- Marcelo Gabriel Kazanietz$22,841,058
- Rahim R Rizi$49,177,138
- Trevor M. Penning$29,812,455
Others in their field
Top investigators on “Oxidation-Reduction”
- Stuart A Lipton · Burnham Institute For Medical Research$22,352,588
- Yvonne M.w. Janssen-Heininger · University Of Vermont &St Agric College$16,004,795
- Joshua N. Adkins · Battelle Pacific Northwest Laboratories$14,698,503
- Stephen W Ragsdale · University Of Nebraska Lincoln$13,916,230
- Vadim N. Gladyshev · University Of Nebraska Lincoln$13,299,162
- Andres Vazquez-Torres · Va Eastern Colorado Health Care System$12,422,594
Research focus
Oxidation-ReductionImageMetabolicCell ModelTumorFluorescence ImagingXenograft ProcedureFlavoproteinsMalignant Breast NeoplasmMitochondriaBreast Cancer CellMetabolismMalignant NeoplasmsDiabetes MellitusFutureImaging ModalityIn VivoCoupledMetastatic ToBreast Cancer PatientCellsMediatingMeasurementMelanoma
Grant awards (20)
Label-Free Optical Redox Imaging for Pretreatment Prognosis of Early-Stage Triple Negative Breast Cancer$673,463
R01 · FY2025 · CA · contact PI
Label-Free Optical Redox Imaging for Pretreatment Prognosis of Early-Stage Triple Negative Breast Cancer$626,956
R01 · FY2024 · CA · contact PI
The Third Britton Chance International Symposium on Metabolic Imaging and Spectroscopy$16,500
R13 · FY2024 · EB · contact PI
Label-Free Optical Redox Imaging for Pretreatment Prognosis of Early-Stage Triple Negative Breast Cancer$675,960
R01 · FY2023 · CA · contact PI
Redox imaging for breast cancer prognosis$589,750
R01 · FY2019 · CA · contact PI
Redox imaging for breast cancer prognosis$622,003
R01 · FY2018 · CA · contact PI
Redox imaging for breast cancer prognosis$634,016
R01 · FY2017 · CA · contact PI
Redox imaging for breast cancer prognosis$653,379
R01 · FY2016 · CA · contact PI
The 2nd Britton Chance International Symposium on Metabolic Imaging and Spectroscopy$20,000
R13 · FY2016 · EB · contact PI
Redox imaging for breast cancer prognosis$662,704
R01 · FY2015 · CA · contact PI
Imaging Mitochondrial Redox States In Vivo by Hyperpolarized MR$380,028
R01 · FY2015 · CA · contact PI
Imaging Mitochondrial Redox States In Vivo by Hyperpolarized MR$369,173
R01 · FY2014 · CA · contact PI
Imaging Mitochondrial Redox States In Vivo by Hyperpolarized MR$369,102
R01 · FY2013 · CA · contact PI
Britton Chance International Symposium on Metabolic Imaging/Spectroscopy$8,000
R13 · FY2013 · CA · contact PI
Imaging Mitochondrial Redox States In Vivo by Hyperpolarized MR$400,008
R01 · FY2012 · CA · contact PI
Imaging Mitochondrial Redox States In Vivo by Hyperpolarized MR$407,904
R01 · FY2011 · CA · contact PI
MR SUSCEPTIBILITY QUANTIFICATION &ITS MEDICAL APPLICATIONS$9,104
P41 · FY2004 · RR
MAGNETIC FIELD &APPLICATION FOR MR SUSCEPTIBILITY QUANTIFICATION$225,543
P41 · FY2002 · RR
MAGNETIC FIELD &APPLICATION FOR MR SUSCEPTIBILITY QUANTIFICATION$225,543
P41 · FY2001 · RR
MAGNETIC FIELD &APPLICATION FOR MR SUSCEPTIBILITY QUANTIFICATION$28,012
P41 · FY2000 · RR